(219 days)
Not Found
No
The device description focuses on the physical components and materials of a surgical sling system and does not mention any software, algorithms, or data processing capabilities that would indicate the use of AI or ML.
Yes
The device is intended for the placement of a pubourethral or suburethral sling/mesh to treat female stress urinary incontinence, which is a medical condition. The implantable mesh is designed to remain in the body as a permanent implant to provide a therapeutic effect.
No
The device is described as a system for the surgical placement of a sling or mesh to treat stress urinary incontinence, indicating a therapeutic rather than diagnostic purpose.
No
The device description clearly outlines physical components such as stainless steel needle passers, polypropylene mesh, plastic handles, sheaths, and connectors. These are all hardware components, indicating the device is not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the surgical placement of a pubourethral or suburethral sling/mesh for the treatment of female stress urinary incontinence. This is a surgical procedure performed on the patient's body.
- Device Description: The device consists of surgical tools (needle passers) and an implantable mesh. These are physical devices used in a surgical procedure.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue samples, etc.) to provide information for diagnosis, monitoring, or treatment.
IVD devices are used in vitro (outside the body) to analyze biological samples. This device is used in vivo (inside the body) as a surgical implant.
N/A
Intended Use / Indications for Use
Sparc™ Sling System (Sparc):
Intended for the placement of pubourethral sling for the treatment of female stress urinary incontinence (SUI) resulting from urethral hypermobility and for intrinsic sphincter deficiency.
Monarc, Monarc + and Monarc C Subfascial Hammock (Monarc) device: Intended for the placement of suburethral mesh for the treatment of female stress urinary incontinence (SUI) resulting from urethral hypermobility and for intrinsic sphincter deficiency.
Product codes (comma separated list FDA assigned to the subject device)
OTN
Device Description
The Sparc device is a sterile, single use procedure kit consisting of:
- Two stainless steel, curved, 21-cm long, needle passers. One end of each . needle passer is keved to allow for secure placement of the connectors. Each needle passer has a plastic handle attached.
- One piece of AMS Polypropylene sling mesh with attached connectors. The AMS . Polypropylene sling mesh is constructed of polypropylene monofilament that is precut to 1.1 cm width x 50 cm length. An absorbable tensioning suture is threaded into the length of the sling mesh to allow for tensioning adjustment of the sling mesh after placement in the patient is achieved. Two plastic sheaths that overlap in the center of the sling mesh cover the sling mesh and protect it during placement. The connectors are attached to the vaginal ends of the Sparc needle passers during the procedure. The AMS Polypropylene sling mesh is intended to remain in the body as a permanent implant and the mesh component is not absorbed or degraded by the action of tissue ingrowth or tissue enzymes.
The Monarc devices are sterile, single use procedure kits, each consisting of:
- Two stainless steel, curved needle passers. The tip portion of each needle . passer is configured to allow for secure placement of the connectors. Each needle passer has a plastic handle attached.
- An assembly including one piece of loosely knitted polypropylene mesh, two . removable plastic insertion sheaths attached to the mesh, and two connectors attached to the insertion sheaths. The mesh is constructed of polypropylene monofilament. An absorbable tensioning suture is threaded into the length of the mesh to allow for tensioning adjustment of the mesh after placement in the patient is achieved. The plastic covering also affords convenient travel of the mesh through the tissue. The connectors are attached to the tip portions of the Monarc needle passers during the procedure. The loosely knitted polypropylene mesh is intended to remain in the body as a permanent implant. The mesh component is not absorbed or degraded by the action of tissue in-growth or tissue enzymes.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 878.3300 Surgical mesh.
(a)
Identification. Surgical mesh is a metallic or polymeric screen intended to be implanted to reinforce soft tissue or bone where weakness exists. Examples of surgical mesh are metallic and polymeric mesh for hernia repair, and acetabular and cement restrictor mesh used during orthopedic surgery.(b)
Classification. Class II.
0
| 510(k) Summary | ||
|---|---|---|
| Date Prepared: | November 1, 2013 | |
| Submitter's Name/ Address: | American Medical Systems, Inc. | |
| 10700 Bren Road West | ||
| Minnetonka, MN 55343 | DEC 0 5 2013 | |
| Owner/Operator | American Medical Systems, Inc. | |
| 10700 Bren Road West | ||
| Minnetonka, MN 55343 | ||
| Establishment Registration Number: 2183959 | ||
| Manufacturing Site | American Medical Systems Ireland Ltd. | |
| Athlone Business and Technology Park, Unit A | ||
| Garrycastle, Dublin Road | ||
| Athlone, Co. Westmeath | ||
| Ireland | ||
| FDA Establishment Registration Number: 3009433692 | ||
| Sterilization | Synergy Heath Ireland Ltd. | |
| IDA Business & Technology Park | ||
| Sragh | ||
| Tullamore | ||
| Co. Offaly | ||
| Ireland | ||
| FDA Establishment Registration Number: 3002807314 |
Submission Contact Information:
| Primary Contact: | David H. Mueller
Principal Regulatory Affairs Specialist
Telephone: (952)930-6577
Fax Number: (952)939-5785
David. Mueller@AMMD.com |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------|
| Alternate Contact: | Melanie Hess
Director, Regulatory Affairs
Telephone: (952)939-6094
Fax Number: (952)939-5785
Melanie. Hess@americanmedicalsystems.com |
1
Proposed Device:
| Device Proprietary Name: | Sparc™ Sling System and Monarc™, Monarc™ + and |
|---|---|
| Monarc™ C Subfascial Hammock | |
| Common Name: | Surgical Mesh |
| Classification Name: | Surgical Mesh, polymeric |
| Class: | Class II / 21 CFR 878.3300 |
| Product Code: | OTN |
Predicate Devices:
Sparc Sling System (Sparc) and Monarc, Monarc + and Monarc C Subfascial Hammock (Monarc) device; K081613
Proposed Device Description:
The Sparc and Monarc related device descriptions are as followed:
The Sparc device is a sterile, single use procedure kit consisting of:
- Two stainless steel, curved, 21-cm long, needle passers. One end of each . needle passer is keved to allow for secure placement of the connectors. Each needle passer has a plastic handle attached.
- One piece of AMS Polypropylene sling mesh with attached connectors. The AMS . Polypropylene sling mesh is constructed of polypropylene monofilament that is precut to 1.1 cm width x 50 cm length. An absorbable tensioning suture is threaded into the length of the sling mesh to allow for tensioning adjustment of the sling mesh after placement in the patient is achieved. Two plastic sheaths that overlap in the center of the sling mesh cover the sling mesh and protect it during placement. The connectors are attached to the vaginal ends of the Sparc needle passers during the procedure. The AMS Polypropylene sling mesh is intended to remain in the body as a permanent implant and the mesh component is not absorbed or degraded by the action of tissue ingrowth or tissue enzymes.
The Monarc devices are sterile, single use procedure kits, each consisting of:
- Two stainless steel, curved needle passers. The tip portion of each needle . passer is configured to allow for secure placement of the connectors. Each needle passer has a plastic handle attached.
- An assembly including one piece of loosely knitted polypropylene mesh, two . removable plastic insertion sheaths attached to the mesh, and two connectors attached to the insertion sheaths. The mesh is constructed of polypropylene
2
monofilament. An absorbable tensioning suture is threaded into the length of the mesh to allow for tensioning adjustment of the mesh after placement in the patient is achieved. The plastic covering also affords convenient travel of the mesh through the tissue. The connectors are attached to the tip portions of the Monarc needle passers during the procedure. The loosely knitted polypropylene mesh is intended to remain in the body as a permanent implant. The mesh component is not absorbed or degraded by the action of tissue in-growth or tissue enzymes.
Proposed Device Intended Use (Indication for Use):
Sparc Sling System (Sparc):
Intended for the placement of pubourethral sling for the treatment of female stress urinary incontinence (SUI) resulting from urethral hypermobility and for intrinsic sphincter deficiency.
Monarc, Monarc + and Monarc C Subfascial Hammock (Monarc) device: Intended for the placement of suburethral mesh for the treatment of female stress urinary incontinence (SUI) resulting from urethral hypermobility and for intrinsic sphincter deficiency.
Summary of the Technical Characteristics Compared to the Predicate Device(s):
All characteristics of the proposed device are identical to those of the predicate, including design, material construction, manufacturing process, and intended use. There is no change to the technical characteristics for this 510(k).
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like symbol with three curved lines representing its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the symbol.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
December 5, 2013
American Medical Systems, Inc. David H. Mueller Principal Regulatory Affairs Specialist 10700 Bren Road West Minnetonka, MN 55343
Re: K131229
Trade/Device Name: Sparc™ Sling System and MonarcTM, Monarc™ + and MonarcTM C Subfascial Hammock Systems
Regulation Number: 21 CFR§ 878.3300 Regulation Name: Surgical mesh Regulatory Class: II Product Code: OTN Dated: November 1, 2013 Received: November 6, 2013
Dear David H. Mueller,
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
4
Page 2 - David H. Mueller
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Herbert P. Lerner -S
for
Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
American Medical Systems K131229/ Amendment 1: Special 510(k) Submission Changes Being Effected Spare™ Sling System and Monarc™, Monarc™ + and Monarc™ C Subfascial Hammock
Section 4
Indication for Use Statement
510{k} Number: K131229
Device Name: Sparc™ Sling System and Monarc™, Monarc™ + and Monarc™ C Subfascial HammockSystems
Indications for Use:
Sparc System:
Intended for the placement of pubourethral sling for the treatment of female stress urinary incontinence (SUI) resulting from urethral hypermobility and/or intrinsic sphincter deficiency.
Monarc. Monarc + and Monarc C Systems: Intended for the placement of suburethral mesh for the treatment of female stress urinary incontinence (SUI) resulting from urethral hypermobility and/or intrinsic sphincter deficiency.
Prescription Use × (Per 21 CFR 801 Subpart D) Over-The Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
AND/OR
Concurrence of CDRH, Office of Device Evaluation (ODE)